Jayempi Europäische Union - Deutsch - EMA (European Medicines Agency)

jayempi

nova laboratories ireland limited - azathioprine - transplantatabstoßung - immunsuppressiva - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Azaqvida 50 mg Filmtabletten Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

azaqvida 50 mg filmtabletten

aqvida gmbh (8135745) - azathioprin - filmtablette - teil 1 - filmtablette; azathioprin (04347) 50 milligramm

AZA-effect pharma 50 mg Filmtabletten Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

aza-effect pharma 50 mg filmtabletten

effect pharma gmbh (8166941) - azathioprin - filmtablette - teil 1 - filmtablette; azathioprin (04347) 50 milligramm

AZA-effect pharma 25 mg Filmtabletten Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

aza-effect pharma 25 mg filmtabletten

effect pharma gmbh (8166941) - azathioprin - filmtablette - teil 1 - filmtablette; azathioprin (04347) 25 milligramm

Imuran 50 mg Filmtablette Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

imuran 50 mg filmtablette

aspen pharma trading - azathioprin - filmtablette - 50 mg - azathioprin 50 mg - azathioprine

Imuran Mitis 25 mg Filmtablette Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

imuran mitis 25 mg filmtablette

aspen pharma trading - azathioprin - filmtablette - 25 mg - azathioprin 25 mg - azathioprine

Azafalk 75 mg Filmtabletten Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

azafalk 75 mg filmtabletten

dr. falk pharma ag - azathioprinum - filmtabletten - azathioprinum 75 mg, cellulosum microcristallinum, silica colloidalis anhydrica, natrii stearylis fumaras, carmellosum natricum conexum, amylum pregelificatum, povidonum k 25, lactosum monohydricum 86.85 mg, Überzug: poly(alcohol vinylicus), talcum, macrogolum, polysorbatum 80, pro compresso obducto corresp. natrium 1.54 mg. - immunsuppressivum - synthetika

Azafalk 100 mg Filmtabletten Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

azafalk 100 mg filmtabletten

dr. falk pharma ag - azathioprinum - filmtabletten - azathioprinum 100 mg, cellulosum microcristallinum, silica colloidalis anhydrica, natrii stearylis fumaras, carmellosum natricum conexum, amylum pregelificatum, povidonum k 25, lactosum monohydricum 115.8 mg, Überzug: poly(alcohol vinylicus), talcum, macrogolum, polysorbatum 80, pro compresso obducto corresp. natrium 2.06 mg. - immunsuppressivum - synthetika

Azafalk 50 mg Filmtalbetten Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

azafalk 50 mg filmtalbetten

dr. falk pharma ag - azathioprinum - filmtalbetten - azathioprinum 50 mg, cellulosum microcristallinum, silica colloidalis anhydrica, natrii stearylis fumaras, carmellosum natricum conexum, amylum pregelificatum, povidonum k 25, lactosum monohydricum 57.9 mg, Überzug: poly(alcohol vinylicus), talcum, macrogolum, polysorbatum 80, pro compresso obducto corresp. natrium 1.03 mg. - immunsuppressivum - synthetika